Frank Moosig

7.2k total citations · 1 hit paper
102 papers, 3.6k citations indexed

About

Frank Moosig is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Immunology. According to data from OpenAlex, Frank Moosig has authored 102 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Pulmonary and Respiratory Medicine, 70 papers in Rheumatology and 25 papers in Immunology. Recurrent topics in Frank Moosig's work include Vasculitis and related conditions (72 papers), Eosinophilic Disorders and Syndromes (24 papers) and Urticaria and Related Conditions (20 papers). Frank Moosig is often cited by papers focused on Vasculitis and related conditions (72 papers), Eosinophilic Disorders and Syndromes (24 papers) and Urticaria and Related Conditions (20 papers). Frank Moosig collaborates with scholars based in Germany, United States and Austria. Frank Moosig's co-authors include Elena Csernok, Wolfgang L. Gross, Julia U. Holle, Konstanze Holl‐Ulrich, Peter Lamprecht, Peter A. Merkel, E. Reinhold‐Keller, Martin Laudien, Jochen Zwerina and A. Schnabel and has published in prestigious journals such as New England Journal of Medicine, Journal of Allergy and Clinical Immunology and European Heart Journal.

In The Last Decade

Frank Moosig

93 papers receiving 3.5k citations

Hit Papers

Mepolizumab or Placebo for Eosinophilic Granulomatosis wi... 2017 2026 2020 2023 2017 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
    2017 589 citations Frank Moosig et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Moosig Germany 32 2.6k 1.9k 1.0k 807 518 102 3.6k
Peter Lamprecht Germany 33 2.1k 0.8× 1.2k 0.6× 687 0.7× 1.2k 1.5× 284 0.5× 159 3.6k
J. W. Cohen Tervaert Netherlands 36 2.6k 1.0× 1.1k 0.6× 830 0.8× 1.3k 1.6× 306 0.6× 77 3.8k
José Hernández‐Rodríguez Spain 39 3.1k 1.2× 2.2k 1.1× 406 0.4× 978 1.2× 411 0.8× 131 4.3k
E. Reinhold‐Keller Germany 31 3.0k 1.2× 1.6k 0.8× 1.4k 1.4× 413 0.5× 233 0.4× 74 3.5k
Achille Aouba France 30 1.4k 0.5× 1.2k 0.6× 694 0.7× 433 0.5× 373 0.7× 157 2.8k
Divi Cornec France 34 1.0k 0.4× 1.2k 0.6× 1.6k 1.6× 868 1.1× 964 1.9× 173 3.8k
Christina Duftner Austria 26 1.2k 0.5× 1.5k 0.8× 389 0.4× 1.0k 1.3× 254 0.5× 84 3.0k
K.H. Ly France 31 1.3k 0.5× 1.2k 0.6× 421 0.4× 376 0.5× 254 0.5× 139 2.7k
L Guillevin France 24 2.0k 0.8× 1.2k 0.6× 797 0.8× 383 0.5× 362 0.7× 96 3.1k
Sergio Prieto‐González Spain 27 1.6k 0.6× 1.2k 0.6× 255 0.2× 460 0.6× 200 0.4× 90 2.3k

Countries citing papers authored by Frank Moosig

Since Specialization
Citations

This map shows the geographic impact of Frank Moosig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Moosig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Moosig more than expected).

Fields of papers citing papers by Frank Moosig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Moosig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Moosig. The network helps show where Frank Moosig may publish in the future.

Co-authorship network of co-authors of Frank Moosig

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Moosig. A scholar is included among the top collaborators of Frank Moosig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Moosig. Frank Moosig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kernder, Anna, Kirsten de Groot, Bernhard Hellmich, et al.. (2023). COVID-19 pandemic impairs medical care of vasculitis patients in Germany: Results of a national patient survey. Frontiers in Medicine. 9. 1103694–1103694. 2 indexed citations
2.
Baerlecken, Niklas, Torsten Witte, Katja Kniesch, et al.. (2020). Presence of Antibodies Binding to Negative Elongation Factor E in Sarcoidosis. Journal of Clinical Medicine. 9(3). 715–715. 1 indexed citations
3.
Schulze‐Koops, Hendrik, Julia U. Holle, Frank Moosig, et al.. (2020). Aktuelle Handlungsempfehlungen der Deutschen Gesellschaft für Rheumatologie für die Betreuung von Patienten mit rheumatischen Erkrankungen während der SARS-CoV‑2/Covid 19-Pandemie. Zeitschrift für Rheumatologie. 79(4). 385–388. 9 indexed citations
4.
Schirmer, Jan Henrik, Peer Aries, Kirsten de Groot, et al.. (2017). S1-Leitlinie Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden. Zeitschrift für Rheumatologie. 76(S3). 77–104. 37 indexed citations
5.
Kerstein, Anja, Otávio Cabral-Marques, Robert Häsler, et al.. (2016). Environmental factor and inflammation-driven alteration of the total peripheral T-cell compartment in granulomatosis with polyangiitis. Journal of Autoimmunity. 78. 79–91. 29 indexed citations
6.
Schirmer, Jan Henrik, Konstanze Holl‐Ulrich, & Frank Moosig. (2014). Polyarteriitis nodosa. Zeitschrift für Rheumatologie. 73(10). 917–927. 2 indexed citations
7.
Moosig, Frank, et al.. (2014). Vorhofmyxom mit klinischem Bild einer entzündlichen Systemerkrankung. Zeitschrift für Rheumatologie. 73(3). 281–284. 2 indexed citations
8.
Csernok, Elena & Frank Moosig. (2014). Current and emerging techniques for ANCA detection in vasculitis. Nature Reviews Rheumatology. 10(8). 494–501. 104 indexed citations
9.
Herrmann, Kristine, Wolfgang L. Gross, & Frank Moosig. (2012). Extended follow-up after stopping mepolizumab in relapsing/refractory Churg-Strauss syndrome.. PubMed. 30(1 Suppl 70). S62–5. 47 indexed citations
10.
Moosig, Frank & Bernhard Hellmich. (2012). Update Churg-Strauss-Syndrom. Zeitschrift für Rheumatologie. 71(9). 765–770. 1 indexed citations
11.
Vaglio, Augusto, Frank Moosig, & Jochen Zwerina. (2011). Churg–Strauss syndrome. Current Opinion in Rheumatology. 24(1). 24–30. 56 indexed citations
12.
Wieczorek, Stefan, Julia U. Holle, Jan Phillip Bremer, et al.. (2010). Contrasting association of a non-synonymous leptin receptor gene polymorphism with Wegener’s granulomatosis and Churg–Strauss syndrome. Lara D. Veeken. 49(5). 907–914. 18 indexed citations
13.
Holle, Julia U., Wolfgang L. Gross, Konstanze Holl‐Ulrich, et al.. (2010). Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?. Annals of the Rheumatic Diseases. 69(11). 1934–1939. 140 indexed citations
14.
Moosig, Frank, Julia U. Holle, & Wolfgang L. Gross. (2009). Value of anti-infective chemoprophylaxis in primary systemic vasculitis: what is the evidence?. Arthritis Research & Therapy. 11(5). 253–253. 31 indexed citations
15.
Holle, Julia U., Frank Moosig, & Wolfgang L. Gross. (2009). Diagnostic and therapeutic management of Churg–Strauss syndrome. Expert Review of Clinical Immunology. 5(6). 813–823. 5 indexed citations
16.
Both, Marcus, et al.. (2009). Großgefäßvaskulitiden. Der Radiologe. 49(10). 947–966.
17.
Both, Marcus, B. Nölle, Christina Forstner, et al.. (2009). Bildgebende Techniken zur Diagnostik primärer Großgefäßvaskulitiden. Zeitschrift für Rheumatologie. 68(6). 471–484. 5 indexed citations
18.
Moosig, Frank, Frédérik Damm, Matthias Ritgen, et al.. (2006). Reduced expression of C1q-mRNA in monocytes from patients with systemic lupus erythematosus. Clinical & Experimental Immunology. 146(3). 409–416. 24 indexed citations
19.
20.
Lamprecht, Peter, Elena Csernok, Antje Mueller, et al.. (2002). Peripheral Blood and Granuloma CD4+CD28− T Cells Are a Major Source of Interferon-γ and Tumor Necrosis Factor-α in Wegener’s Granulomatosis. American Journal Of Pathology. 160(5). 1717–1724. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Lamprecht Breakdown of academic impact, for papers by J. W. Cohen Tervaert Breakdown of academic impact, for papers by José Hernández‐Rodríguez Breakdown of academic impact, for papers by E. Reinhold‐Keller Breakdown of academic impact, for papers by Achille Aouba Breakdown of academic impact, for papers by Divi Cornec Breakdown of academic impact, for papers by Christina Duftner Breakdown of academic impact, for papers by K.H. Ly Breakdown of academic impact, for papers by L Guillevin Breakdown of academic impact, for papers by Sergio Prieto‐González
Rankless by CCL
2026